Analystreport

Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.

Merrimack Pharmaceuticals, Inc.  (MACK) 
Last merrimack pharmaceuticals, inc. earnings: 3/6 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.merrimack.com/investor-relations